US4844732A
(en)
|
1985-10-24 |
1989-07-04 |
Daicel Chemical Industries Ltd. |
Pyridine-3-carboxamide derivatives
|
JPH075555B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
ピリドン−3−カルボキサミドの製法
|
JPH075554B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
5−ブロモピリドン−3−カルボキサミド化合物の製法
|
AU6062590A
(en)
|
1989-07-07 |
1991-02-06 |
Schering Corporation |
Pharmaceutically active compounds
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
FR2665440B1
(fr)
|
1990-07-31 |
1994-02-04 |
Lipha |
Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
|
JPH05107574A
(ja)
|
1991-03-12 |
1993-04-30 |
Mitsui Petrochem Ind Ltd |
有機非線形光学材料
|
JPH06509069A
(ja)
|
1991-06-27 |
1994-10-13 |
バージニア・コモンウェルス・ユニバーシティ |
シグマレセプターリガンドおよびその用途
|
US5356897A
(en)
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
IT1254134B
(it)
|
1992-01-16 |
1995-09-08 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso chimicamente modificati.
|
IT1254469B
(it)
|
1992-02-25 |
1995-09-25 |
Recordati Chem Pharm |
Derivati benzopiranici e benzotiopiranici
|
SG65570A1
(en)
|
1992-02-25 |
1999-06-22 |
Recordati Chem Pharm |
Heterobicyclic compounds
|
CA2144763A1
(en)
|
1992-10-14 |
1994-04-28 |
George D. Hartman |
Fibrinogen receptor antagonists
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
GB2300856A
(en)
|
1995-05-16 |
1996-11-20 |
Pfizer Ltd |
Beta-lactam preparation
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
AU4153496A
(en)
|
1995-10-20 |
1997-05-07 |
Flora Inc. |
Transdermal delivery of alpha adrenoceptor blocking agents
|
US6066738A
(en)
|
1996-01-30 |
2000-05-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
FR2746309B1
(fr)
|
1996-03-22 |
1998-04-17 |
Oreal |
Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture
|
HUP0001107A3
(en)
|
1996-10-16 |
2003-01-28 |
Icn Pharmaceuticals Inc Costa |
Monocyclic l-nucleosides, analogs and pharmaceutical compositions thereof
|
ES2212814T3
(es)
|
1996-10-31 |
2004-08-01 |
Harbor Branch Oceanographic Institution, Inc. |
Uso de compuestos y composiciones antiinflamatorias neurogenicas.
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
US5942508A
(en)
|
1997-02-04 |
1999-08-24 |
Senju Pharmaceutical Co., Ltd. |
Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
|
EP1025857A4
(en)
|
1997-10-22 |
2003-11-12 |
Eisai Co Ltd |
RETINOIC ACID AGONISTS, PREVENTIVE AND THERAPEUTIC AGENTS FOR NEPHRITES
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
CN1332722A
(zh)
|
1998-09-30 |
2002-01-23 |
宝洁公司 |
2-取代的酮酰胺
|
AU1230100A
(en)
|
1998-10-29 |
2000-05-22 |
Merck & Co., Inc. |
A method of treating endometriosis
|
KR100693771B1
(ko)
|
1999-04-28 |
2007-03-12 |
사노피-아벤티스 도이칠란트 게엠베하 |
Ppar 수용체 리간드로서의 트리아릴 산 유도체 및 이를 포함하는 약제학적 조성물
|
WO2001012183A1
(en)
|
1999-08-16 |
2001-02-22 |
Merck & Co., Inc. |
Heterocycle amides as cell adhesion inhibitors
|
NZ517828A
(en)
|
1999-09-17 |
2003-10-31 |
Millennium Pharm Inc |
Inhibitors having activity against mammalian factor Xa
|
WO2001019788A2
(en)
|
1999-09-17 |
2001-03-22 |
Cor Therapeutics, Inc. |
BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
|
PL357083A1
(en)
|
1999-10-29 |
2004-07-12 |
Pfizer Products Inc. |
Hygromycin derivatives
|
CZ20021548A3
(cs)
|
1999-11-05 |
2002-10-16 |
Societe De Conseils De Recherches Et D'application |
Nové heterocyklické sloučeniny a jejich pouľití jako léků
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
ES2254385T3
(es)
|
2000-02-29 |
2006-06-16 |
Millennium Pharmaceuticals, Inc. |
Benzamidas e inhibidores relacionados del factor xa.
|
BR0109107A
(pt)
|
2000-03-09 |
2002-12-03 |
Aventis Pharma Gmbh |
Usos terapêuticos de mediadores ppar
|
DK1303757T3
(da)
|
2000-07-10 |
2007-02-05 |
Vertex Pharma San Diego Llc |
Ionkanal-assayfremgangsmåder
|
JP2004508359A
(ja)
|
2000-09-06 |
2004-03-18 |
ニューロゲン コーポレイション |
アリール置換テトラヒドロインダゾール、及び、gaba−a受容体に対するリガンドとしてのそれらの使用
|
AU2002255473A1
(en)
|
2000-10-24 |
2002-09-04 |
Glaxo Group Limited |
Process for preparing intermediates of hiv protease inhibitors
|
JP3786203B2
(ja)
|
2000-11-04 |
2006-06-14 |
アベンティス・フアーマ・リミテッド |
置換アルカン酸
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
MXPA03006250A
(es)
|
2001-01-16 |
2003-09-22 |
Astrazeneca Ab |
Compuestos heterociclicos terapeuticos.
|
CA2437840A1
(en)
|
2001-03-05 |
2002-09-12 |
E.I. Du Pont De Nemours |
Heterocyclic diamide invertebrate pest control agents
|
EP1381592A1
(en)
|
2001-04-13 |
2004-01-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused compounds
|
JP2003034671A
(ja)
|
2001-05-17 |
2003-02-07 |
Nippon Nohyaku Co Ltd |
ベンズアミド誘導体及び農園芸用薬剤並びにその使用方法
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
US20050080112A1
(en)
|
2001-06-22 |
2005-04-14 |
Madsen Lars Siim |
Compounds for use in disorders associated with mast cell or basophil acitvity
|
GEP20074098B
(en)
|
2001-09-21 |
2007-05-10 |
Bristol Myers Squibb Co |
Lactam-containing compounds and derivatives thereof as factor xa inhibitors
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
WO2003045921A1
(en)
|
2001-11-28 |
2003-06-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
US7157475B2
(en)
|
2002-01-22 |
2007-01-02 |
E. I. Du Pont De Nemours And Company |
Diamide invertebrate pest control agents
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
ES2334990T3
(es)
|
2002-02-14 |
2010-03-18 |
Pharmacia Corporation |
Piridinonas sustituidas como moduladores de p38 map quinasa.
|
US20050250831A1
(en)
|
2002-02-21 |
2005-11-10 |
Gibson Tracey A |
Peroxisome proliferator activated receptor modulators
|
WO2003072757A2
(en)
|
2002-02-28 |
2003-09-04 |
Biota, Inc. |
Nucleotide mimics and their prodrugs
|
AU2003237224A1
(en)
*
|
2002-05-29 |
2003-12-19 |
Merck And Co., Inc. |
1,2 diamido cycloalkyl sodium channel blockers
|
US7622592B2
(en)
|
2002-11-01 |
2009-11-24 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
EP1581539A4
(en)
|
2003-01-03 |
2007-09-19 |
Bristol Myers Squibb Co |
NEW TYROSINE KINASE HEMMER
|
EA011808B1
(ru)
|
2003-01-08 |
2009-06-30 |
Новартис Вэксинес Энд Дайэгностикс, Инк. |
Антибактериальные агенты
|
US7122557B2
(en)
|
2003-03-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
|
US7365178B2
(en)
|
2003-04-01 |
2008-04-29 |
Activx Biosciences, Inc. |
Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
EP1635824B1
(en)
|
2003-06-03 |
2009-08-19 |
Novartis AG |
5-membered heterocycle-based p-38 inhibitors
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
TW200524888A
(en)
|
2003-08-08 |
2005-08-01 |
Vertex Pharma |
Compositions useful as inhibitors of voltage-gated ion channels
|
BRPI0413684A
(pt)
|
2003-08-21 |
2006-10-24 |
Univ Griffith |
compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
|
EP1664071A1
(en)
|
2003-08-21 |
2006-06-07 |
Griffith University |
Novel sulfenamide oxides
|
KR20060123707A
(ko)
|
2003-08-27 |
2006-12-04 |
바이오타, 인코포레이티드 |
치료제로서의 신규 트리시클릭 뉴클레오시드 또는뉴클레오티드
|
JP4795022B2
(ja)
|
2003-09-30 |
2011-10-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環化合物を含有する新規な抗真菌剤
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
JP4526801B2
(ja)
|
2003-11-13 |
2010-08-18 |
新日鐵化学株式会社 |
複素環化合物の製造方法
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
CA2545192A1
(en)
|
2003-11-25 |
2005-06-09 |
Pfizer Products Inc. |
Method of treatment of atherosclerosis
|
EP1802580A2
(en)
|
2004-07-23 |
2007-07-04 |
Pfizer, Inc. |
Pyridine derivatives
|
AU2005274681A1
(en)
|
2004-08-16 |
2006-02-23 |
Verva Pharmaceuticals Pty Ltd |
Metabolism-modulating agents and uses therefor
|
DE602005015231D1
(de)
|
2004-09-02 |
2009-08-13 |
Vertex Pharma |
Als ionenkanalmodulatoren geeignete chinazoline
|
AU2006222563A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
WO2006113615A2
(en)
|
2005-04-15 |
2006-10-26 |
Sloan-Kettering Institute For Cancer Research |
Anti-microbial agents and uses thereof
|
MX2007014187A
(es)
|
2005-05-09 |
2008-01-24 |
Vertex Pharma |
Procesos para preparar biaril ureas y analogos de las mismas.
|
WO2006124780A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
US7683066B2
(en)
|
2005-05-20 |
2010-03-23 |
Vertex Pharmaceuticals Incorporated |
Isoquinolines useful as modulators of ion channels
|
EP1904491A2
(en)
|
2005-05-31 |
2008-04-02 |
Vertex Pharmaceuticals Incorporated |
Heterocycles useful as modulators of ion channels
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
JP2009512695A
(ja)
|
2005-10-21 |
2009-03-26 |
グラクソ グループ リミテッド |
化合物
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
WO2007081966A2
(en)
|
2006-01-09 |
2007-07-19 |
University Of Southern California |
Small molecules for treating cancer and abnormal cell proliferation disorders
|
PE20071025A1
(es)
|
2006-01-31 |
2007-10-17 |
Mitsubishi Tanabe Pharma Corp |
Compuesto amina trisustituido
|
WO2007097940A2
(en)
|
2006-02-13 |
2007-08-30 |
Trustees Of Boston University |
Reca inhibitors with antibiotic activity, compositions and methods of use
|
AR059826A1
(es)
|
2006-03-13 |
2008-04-30 |
Univ California |
Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
|
US7480400B2
(en)
|
2006-03-16 |
2009-01-20 |
Siemens Medical Solutions Usa, Inc. |
Detection of fiber pathways
|
MX2008013194A
(es)
|
2006-04-11 |
2008-12-01 |
Vertex Pharma |
Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
|
WO2007146712A2
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
EP2035395A2
(en)
|
2006-06-27 |
2009-03-18 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
EP1882475A1
(en)
|
2006-07-26 |
2008-01-30 |
Novartis AG |
Method of treating disorders mediated by the fibroblast growth factor receptor
|
MY157177A
(en)
|
2006-08-08 |
2016-05-13 |
Millennium Pharm Inc |
Heteroaryl compounds useful as inhibitors of e1 activating enzymes
|
JP5244596B2
(ja)
|
2006-08-09 |
2013-07-24 |
株式会社アイエスティー |
タンパク質の検出方法及びそれに用いる蛍光色素
|
EP2061758A4
(en)
|
2006-09-11 |
2011-11-30 |
Curis Inc |
A ZINC BINDING GROUP CONTAINING SUBSTITUTED 2-INDOLINONE AS PTK INHIBITORS
|
AU2007296743B2
(en)
|
2006-09-11 |
2012-02-16 |
Curis, Inc. |
Tyrosine kinase inhibitors containing a zinc binding moiety
|
TW200833695A
(en)
|
2006-10-12 |
2008-08-16 |
Xenon Pharmaceuticals Inc |
Use of spiro-oxindole compounds as therapeutic agents
|
WO2008065068A2
(en)
|
2006-11-27 |
2008-06-05 |
Novartis Ag |
Substituted dihydroimidazoles and their use in the treatment of tumors
|
RU2452484C2
(ru)
|
2006-12-08 |
2012-06-10 |
Милленниум Фармасьютикалз, Инк. |
Стандартные лекарственные препараты и способы лечения тромбоза пероральным введением ингибитора фактора ха
|
WO2008133753A2
(en)
|
2006-12-20 |
2008-11-06 |
Abbott Laboratories |
Anti-viral compounds
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2008094507A2
(en)
|
2007-01-26 |
2008-08-07 |
Cellicon Biotechnologies, Inc. |
Novel fusion compounds
|
US20080234297A1
(en)
|
2007-03-20 |
2008-09-25 |
Changgeng Qian |
HSP90 Inhibitors Containing a Zinc Binding Moiety
|
WO2008115263A2
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Raf kinase inhibitors containing a zinc binding moiety
|
CN101675040A
(zh)
*
|
2007-05-03 |
2010-03-17 |
辉瑞有限公司 |
作为钠通道调节剂的2-吡啶甲酰胺衍生物
|
EP2167058B1
(en)
|
2007-06-18 |
2015-08-12 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
CN101687815A
(zh)
|
2007-06-26 |
2010-03-31 |
塞诺菲-安万特股份有限公司 |
苯并咪唑和氮杂苯并咪唑的区域选择性铜催化合成
|
NZ582057A
(en)
|
2007-07-19 |
2012-03-30 |
Lundbeck & Co As H |
5-membered heterocyclic amides and related compounds
|
JP4846769B2
(ja)
|
2007-07-30 |
2011-12-28 |
田辺三菱製薬株式会社 |
医薬組成物
|
JP4834699B2
(ja)
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
WO2009036066A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Vegfr inhibitors containing a zinc binding moiety
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
CA2700088A1
(en)
|
2007-09-26 |
2009-04-02 |
Astellas Pharma Inc. |
Quinolone derivative
|
US8501955B2
(en)
|
2007-10-08 |
2013-08-06 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal application
|
JP5555169B2
(ja)
|
2007-10-11 |
2014-07-23 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド
|
EP2212290B1
(en)
|
2007-10-11 |
2014-12-03 |
Vertex Pharmaceuticals Incorporated |
Aryl amides useful as inhibitors of voltage-gated sodium channels
|
KR20100066583A
(ko)
|
2007-10-11 |
2010-06-17 |
버텍스 파마슈티칼스 인코포레이티드 |
전압-개폐 나트륨 채널의 억제제로서 유용한 아미드
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
CN101925603B
(zh)
|
2007-12-13 |
2013-12-04 |
沃泰克斯药物股份有限公司 |
囊性纤维化跨膜通道调节因子的调节剂
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
EP2244571A4
(en)
|
2008-01-17 |
2014-02-19 |
Purdue Research Foundation |
SMALL INHIBITORY MOLECULES OF HIV PROTEASES
|
US20120108630A1
(en)
|
2008-02-12 |
2012-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hedgehog Pathway Antagonists and Methods of Use
|
WO2009114470A2
(en)
|
2008-03-10 |
2009-09-17 |
Curis, Inc. |
Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
JP5637982B2
(ja)
|
2008-04-09 |
2014-12-10 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
脂肪酸アミド加水分解酵素の阻害剤
|
US9029408B2
(en)
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
DK2303021T3
(en)
|
2008-06-16 |
2019-04-08 |
Univ Tennessee Res Found |
RELATIONSHIPS FOR TREATING CANCER
|
JP5758292B2
(ja)
|
2008-07-03 |
2015-08-05 |
サートリス ファーマシューティカルズ, インコーポレイテッド |
サーチュイン調節薬としてのベンズイミダゾールおよび関連する類似体
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
US8541569B2
(en)
|
2008-09-06 |
2013-09-24 |
Chemgenes Corporation |
Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
|
CA2735251C
(en)
|
2008-09-06 |
2017-07-11 |
Chemgenes Corporation |
Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
|
US8354444B2
(en)
|
2008-09-18 |
2013-01-15 |
Hoffmann-La Roche Inc. |
Substituted pyrrolidine-2-carboxamides
|
PL2340021T3
(pl)
|
2008-09-18 |
2013-04-30 |
Hoffmann La Roche |
Podstawione pirolidyno-2-karboksyamidy
|
CN102227417B
(zh)
|
2008-09-29 |
2015-09-16 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的色烯酮类似物
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
EP2184273A1
(de)
|
2008-11-05 |
2010-05-12 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
US20120165304A1
(en)
|
2008-11-27 |
2012-06-28 |
Boehringer Ingelheim International Gmbh |
6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
JP2012511514A
(ja)
|
2008-12-10 |
2012-05-24 |
メルク・カナダ・インコーポレイテツド |
レニン阻害剤としての3,4−置換ピペリジン誘導体
|
WO2010075282A1
(en)
|
2008-12-22 |
2010-07-01 |
University Of Washington |
Molecular inhibitors of the wnt/beta-catenin pathway
|
EP2382202A1
(en)
|
2008-12-23 |
2011-11-02 |
F. Hoffmann-La Roche AG |
Dihydropyridone amides as p2x7 modulators
|
LT2380881T
(lt)
|
2008-12-26 |
2017-04-10 |
Sumitomo Dainippon Pharma Co., Ltd. |
Naujas biciklinis heterociklinis junginys
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
US8975247B2
(en)
|
2009-03-18 |
2015-03-10 |
The Board Of Trustees Of The Leland Stanford Junion University |
Methods and compositions of treating a flaviviridae family viral infection
|
CN104030987B
(zh)
|
2009-04-02 |
2017-04-12 |
默克雪兰诺有限公司 |
二氢乳清酸脱氢酶抑制剂
|
TWI687408B
(zh)
|
2009-04-28 |
2020-03-11 |
美商環球展覽公司 |
具有甲基-d3取代之銥錯合物
|
US9174999B2
(en)
|
2009-05-07 |
2015-11-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for studying, imaging, and treating pain
|
WO2010138575A1
(en)
|
2009-05-27 |
2010-12-02 |
Abbott Laboratories |
Pyrimidine inhibitors of kinase activity
|
JP2012528175A
(ja)
|
2009-05-27 |
2012-11-12 |
アボット・ラボラトリーズ |
キナーゼ活性のピリミジン阻害剤
|
CA2761639C
(en)
|
2009-05-29 |
2016-06-07 |
Raqualia Pharma Inc. |
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
US8927513B2
(en)
|
2009-07-07 |
2015-01-06 |
Alnylam Pharmaceuticals, Inc. |
5′ phosphate mimics
|
US8629149B2
(en)
|
2009-09-04 |
2014-01-14 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
WO2011032169A2
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
WO2011037731A1
(en)
|
2009-09-25 |
2011-03-31 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
KR20180051676A
(ko)
|
2009-10-16 |
2018-05-16 |
멜린타 테라퓨틱스, 인크. |
항미생물성 화합물 및 이의 제조 방법 및 사용 방법
|
MX2012009561A
(es)
*
|
2010-02-17 |
2012-11-23 |
Amgen Inc |
Carboxamidas como inhibidores de canales de sodio dependientes del voltaje.
|
US11084811B2
(en)
|
2010-03-01 |
2021-08-10 |
Oncternal Therapeutics, Inc. |
Compounds for treatment of cancer
|
JP5879273B2
(ja)
|
2010-03-01 |
2016-03-08 |
ジーティーエックス・インコーポレイテッド |
癌を処置するための化合物
|
US8598164B2
(en)
|
2010-05-06 |
2013-12-03 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
JP2013526514A
(ja)
|
2010-05-10 |
2013-06-24 |
ラディカル・セラピューティックス・インコーポレイテッド |
リポ酸およびニトロキシド誘導体およびその使用
|
WO2011151619A1
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile associated disease
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
EP2593434A1
(en)
*
|
2010-07-16 |
2013-05-22 |
Purdue Pharma LP |
Pyridine compounds as sodium channel blockers
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US9290485B2
(en)
|
2010-08-04 |
2016-03-22 |
Novartis Ag |
N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
|
WO2012020725A1
(ja)
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Npy y5受容体拮抗作用を有するヘテロ環誘導体
|
CN103442568A
(zh)
|
2010-10-08 |
2013-12-11 |
Abbvie公司 |
呋喃并[3,2-d]嘧啶化合物
|
GB201017315D0
(en)
|
2010-10-13 |
2010-11-24 |
Antoxis Ltd |
Compound
|
JP2013543480A
(ja)
*
|
2010-10-18 |
2013-12-05 |
ラクオリア創薬株式会社 |
Ttx−s遮断薬としてのアリールアミド誘導体
|
EP2630136A1
(en)
|
2010-10-21 |
2013-08-28 |
Universität des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
FI20106119A0
(fi)
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
GB201020076D0
(en)
|
2010-11-26 |
2011-01-12 |
Liverpool School Tropical Medicine |
Antimalarial compounds
|
KR101514587B1
(ko)
|
2010-11-29 |
2015-04-22 |
화이자 인코포레이티드 |
모노박탐
|
BR112013014660A2
(pt)
|
2010-12-13 |
2016-09-27 |
Neural Pathways Llc |
dispositivo simulador de emg portátil com comprimento de haste ajustável
|
DK2835131T3
(en)
|
2010-12-14 |
2017-12-04 |
Electrophoretics Ltd |
Casein kinase 1 delta inhibitors (CK1 delta)
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
WO2012097330A2
(en)
|
2011-01-14 |
2012-07-19 |
University Of Washington |
Compositions and methods for treating degenerative muscle conditions
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
SI2670752T1
(sl)
|
2011-02-02 |
2016-10-28 |
Vertex Pharmaceuticals Incorporated |
Pirolopirazin-spirociklični piperidin amidi kot modulatorji ionskih kanalčkov
|
JP2012167027A
(ja)
|
2011-02-10 |
2012-09-06 |
Shionogi & Co Ltd |
Npyy5受容体拮抗作用を有する縮合ヘテロ環誘導体
|
EP2675812B1
(en)
|
2011-02-18 |
2017-08-30 |
Vertex Pharmaceuticals Incorporated |
Chroman - spirocyclic piperidine amides as modulators of ion channels
|
ES2786298T3
(es)
|
2011-03-03 |
2020-10-09 |
Zalicus Pharmaceuticals Ltd |
Inhibidores de benzimidazol del canal de sodio
|
AU2012229187B2
(en)
|
2011-03-14 |
2016-11-10 |
Vertex Pharmaceuticals Incorporated |
Morpholine-spirocyclic piperidine amides as modulators of ion channels
|
CA2830234A1
(en)
|
2011-03-15 |
2012-09-20 |
Abbvie Inc. |
Nuclear hormone receptor modulators
|
WO2012129562A2
(en)
|
2011-03-24 |
2012-09-27 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP5866100B2
(ja)
|
2011-04-13 |
2016-02-17 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
JP2014513699A
(ja)
|
2011-05-11 |
2014-06-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
スピロ−オキシインドールmdm2アンタゴニスト
|
US9278910B2
(en)
|
2011-05-31 |
2016-03-08 |
Receptos, Inc. |
GLP-1 receptor stabilizers and modulators
|
US20140094465A1
(en)
|
2011-06-10 |
2014-04-03 |
N30 Pharmaceuticals, Inc. |
Compounds as S-Nitrosoglutathione Reductase Inhibitors
|
JP2014520161A
(ja)
|
2011-06-22 |
2014-08-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
WO2013022740A2
(en)
|
2011-08-05 |
2013-02-14 |
Corning Incorporated |
Gpr35 ligands and the uses thereof
|
SI2755965T1
(sl)
|
2011-09-12 |
2017-12-29 |
Merck Patent Gmbh |
Novi imidazolni amidi kot modulatorji kinazne aktivnosti
|
WO2013049725A2
(en)
|
2011-09-30 |
2013-04-04 |
Tufts University |
Methods of using adenosine a1 receptor activation for treating depression
|
CA2850925C
(en)
|
2011-10-26 |
2017-01-10 |
Pfizer Limited |
(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
|
CN103159738B
(zh)
|
2011-12-19 |
2016-09-07 |
上海泓博智源医药股份有限公司 |
炔基桥连的杂芳香化合物及其应用
|
AU2013209958B2
(en)
|
2012-01-16 |
2017-09-07 |
Vertex Pharmaceuticals Incorporated |
Pyran-spirocyclic piperidine amides as modulators of ion channels
|
FR2985916B1
(fr)
|
2012-01-25 |
2015-12-04 |
Univ Bordeaux Segalen |
Decontamination par hydrogels d'echantillons aqueux contenant des nanoparticules
|
ES2548228T3
(es)
|
2012-02-03 |
2015-10-15 |
Pfizer Inc |
Derivados de bencimidazol e imidazopiridina como moduladores de canal de sodio
|
BR112014019773A8
(pt)
|
2012-02-08 |
2017-07-11 |
Graffinity Pharmaceuticals Gmbh |
Ligantes para anticorpo e proteína de fusão fc para cromatografia de afinidade
|
CN104136576B
(zh)
|
2012-02-22 |
2020-10-16 |
默克专利股份有限公司 |
液晶介质
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
CN104169286B
(zh)
|
2012-03-06 |
2016-06-08 |
辉瑞大药厂 |
用于治疗增殖性疾病的大环衍生物
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
JP5804991B2
(ja)
|
2012-03-19 |
2015-11-04 |
富士フイルム株式会社 |
光反射フィルム、自動車用フロントガラス、建材用ガラス
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
RU2014150492A
(ru)
|
2012-05-30 |
2016-07-20 |
Ф. Хоффманн-Ля Рош Аг |
Замещенные пирролидин-2-карбоксамиды
|
JP5867298B2
(ja)
|
2012-06-06 |
2016-02-24 |
Jsr株式会社 |
フォトレジスト組成物及びレジストパターン形成方法
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
US20140005181A1
(en)
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
US9040498B2
(en)
|
2012-07-06 |
2015-05-26 |
Research Foundation Of The City University Of New York |
1,2,3-Triazolyl purine derivatives
|
JP6256467B2
(ja)
|
2012-07-17 |
2018-01-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロイコトリエン生成を阻害するピラゾール誘導体
|
TW201416362A
(zh)
|
2012-07-19 |
2014-05-01 |
Dainippon Sumitomo Pharma Co |
1-(環烷基羰基)脯胺酸衍生物
|
ES2671194T3
(es)
|
2012-07-27 |
2018-06-05 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de S1P y/o agentes moduladores de ATX
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
WO2014020152A1
(en)
|
2012-08-02 |
2014-02-06 |
Graffinity Pharmaceuticals Gmbh |
Ligands for apheresis and immunoabsorption
|
WO2014039595A1
(en)
|
2012-09-06 |
2014-03-13 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
ES2863538T3
(es)
|
2012-09-20 |
2021-10-11 |
Univ Temple |
Derivados de alquil diarilo sustituidos, métodos de preparación y usos
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
FR2997851B1
(fr)
|
2012-11-09 |
2014-11-28 |
Oreal |
Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
|
WO2014078479A2
(en)
|
2012-11-14 |
2014-05-22 |
The Board Of Regents Of The University Of Texas System |
INHIBITION OF HIF-2α HETERODIMERIZATION WITH HIF1β (ARNT)
|
CA2891013A1
(en)
|
2012-11-16 |
2014-05-22 |
Abdelghani Abe Achab |
Purine inhibitors of human phosphatidylinositol 3-kinase delta
|
CA2892672A1
(en)
|
2012-12-06 |
2014-06-12 |
Merck Sharp & Dohme Corp. |
Disulfide masked prodrug compositions and methods
|
JP2016508145A
(ja)
|
2013-01-08 |
2016-03-17 |
ザヴィラ ファーマシューティカルズ ゲーエムベーハー |
ピリドン誘導体及びウイルス性疾患の治療、改善又は予防におけるそれらの使用
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
DK2951172T3
(en)
|
2013-01-29 |
2017-07-17 |
Redx Pharma Plc |
PYRIDINE DERIVATIVES LIKE SOFT ROCK INHIBITORS
|
TWI659945B
(zh)
|
2013-01-31 |
2019-05-21 |
維泰克斯製藥公司 |
作爲鈉通道調節劑之醯胺
|
PL2953931T3
(pl)
|
2013-01-31 |
2017-09-29 |
Vertex Pharmaceuticals Incorporated |
Pirydonoamidy jako modulatory kanałów sodowych
|
US9139529B2
(en)
|
2013-01-31 |
2015-09-22 |
Vertex Pharmaceuticals Incorporated |
Substituted quinoxalines as sodium channel modulators
|
TWI606048B
(zh)
|
2013-01-31 |
2017-11-21 |
帝人製藥股份有限公司 |
唑苯衍生物
|
WO2014130856A2
(en)
|
2013-02-21 |
2014-08-28 |
Wayne Rothbaum |
Treatment of skeletal-related disorders
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
EP2970340B1
(en)
|
2013-03-14 |
2020-02-12 |
Venatorx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
US9357781B2
(en)
|
2013-05-03 |
2016-06-07 |
Inscent, Inc. |
Honeybee repellents and uses thereof
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
TWI637949B
(zh)
|
2013-06-14 |
2018-10-11 |
塩野義製藥股份有限公司 |
胺基三衍生物及含有其等之醫藥組合物
|
AR096654A1
(es)
|
2013-06-20 |
2016-01-27 |
Ab Science |
Derivados de benzimidazol como inhibidores selectivos de proteína quinasa
|
WO2015003723A1
(en)
|
2013-07-12 |
2015-01-15 |
Københavns Universitet |
Substituted 4-proline derivatives as iglur antagonists
|
WO2015003991A1
(en)
|
2013-07-12 |
2015-01-15 |
Syngenta Participations Ag |
Novel microbiocides
|
JP6730183B2
(ja)
|
2013-07-12 |
2020-07-29 |
ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー |
シストバクトアミド(Cystobactamides)
|
US11203571B2
(en)
|
2013-07-19 |
2021-12-21 |
Vertex Pharmaceuticals Incorporated |
Sulfonamides as modulators of sodium channels
|
JP2016529241A
(ja)
|
2013-07-25 |
2016-09-23 |
フォンダッツィオーネ・テレソン |
Fapp2阻害剤及びそれらの使用
|
US9789096B2
(en)
|
2013-09-04 |
2017-10-17 |
Board Of Regents Of The University Of Texas System |
Methods and compositions for selective and targeted cancer therapy
|
WO2015038596A1
(en)
|
2013-09-11 |
2015-03-19 |
Emory University |
Nucleotide and nucleoside compositions and uses related thereto
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
KR20160060660A
(ko)
|
2013-10-01 |
2016-05-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
친화성 크로마토그래피를 위한 및 치료제의 반감기를 연장시키기 위한 화합물
|
EP3052479A4
(en)
|
2013-10-02 |
2017-10-25 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
WO2015054337A1
(en)
|
2013-10-09 |
2015-04-16 |
Emory University |
Heterocyclic coupling catalysts and methods related thereto
|
SG10201804652VA
(en)
|
2013-12-03 |
2018-07-30 |
Du Pont |
Pyrrolidinones as herbicides
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
US20150167017A1
(en)
|
2013-12-13 |
2015-06-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
NZ760006A
(en)
|
2013-12-13 |
2022-07-29 |
Vertex Pharma |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
EP2883934B1
(en)
|
2013-12-16 |
2019-11-13 |
Merck Patent GmbH |
Liquid-crystalline medium
|
CN106061480B
(zh)
|
2013-12-30 |
2020-02-28 |
莱福斯希医药公司 |
治疗性抑制性化合物
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
AU2015243437B2
(en)
|
2014-04-09 |
2019-08-29 |
Siteone Therapeutics, Inc. |
10',11'-modified saxitoxins useful for the treatment of pain
|
WO2015162244A1
(en)
|
2014-04-25 |
2015-10-29 |
Basf Se |
N-acylamidine compounds
|
JP6295992B2
(ja)
|
2014-05-09 |
2018-03-20 |
信越化学工業株式会社 |
単量体の製造方法
|
US9701627B2
(en)
|
2014-06-16 |
2017-07-11 |
University Of Maryland, Baltimore |
LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
|
WO2015196118A1
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
US20170175129A1
(en)
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
WO2015196128A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
EA201692301A1
(ru)
|
2014-07-01 |
2017-06-30 |
Ремпекс Фармасьютикалз, Инк. |
Производные бороновой кислоты и их терапевтическое применение
|
WO2016007837A1
(en)
|
2014-07-11 |
2016-01-14 |
Spero Therapeutics, Inc. |
Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
|
BR112017000816A2
(pt)
|
2014-07-16 |
2017-12-05 |
Lifesci Pharmaceuticals Inc |
compostos inibitórios terapêuticos
|
EP2977374A1
(en)
|
2014-07-21 |
2016-01-27 |
Université de Strasbourg |
Molecules presenting dual emission properties
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US10913736B2
(en)
|
2014-08-22 |
2021-02-09 |
University Of Washington |
Specific inhibitors of methionyl-tRNA synthetase
|
JP2017538659A
(ja)
|
2014-09-10 |
2017-12-28 |
エピザイム インコーポレイテッド |
Smyd阻害剤
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
JP2016079098A
(ja)
|
2014-10-10 |
2016-05-16 |
塩野義製薬株式会社 |
セフェム化合物
|
WO2016073633A1
(en)
|
2014-11-05 |
2016-05-12 |
University Of Kansas |
SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)
|
CN117137048A
(zh)
|
2014-12-10 |
2023-12-01 |
马斯公司 |
风味组合物、包含该组合物的食品及增加食品鲜味味道强度的方法
|
FR3030242B1
(fr)
|
2014-12-18 |
2018-01-26 |
L'oreal |
Emulsion contenant un tensioactif gemine ayant deux groupements amide gras et un filtre uv organique hydrosoluble
|
CN105985330A
(zh)
|
2015-02-04 |
2016-10-05 |
苏州旺山旺水生物医药有限公司 |
一类杂环化合物、其制备方法和用途
|
JP6394430B2
(ja)
|
2015-02-13 |
2018-09-26 |
信越化学工業株式会社 |
化合物、高分子化合物、レジスト材料及びパターン形成方法
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
EP3085360A1
(en)
|
2015-04-20 |
2016-10-26 |
Universite De Bordeaux |
Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
ES2761824T3
(es)
|
2015-05-15 |
2020-05-21 |
Gilead Sciences Inc |
Compuestos de carboximidamida de benzimidazol y imidazopiridina que tienen actividad como inhibidores de indoleamina 2,3-dioxigenasa
|
WO2016196593A1
(en)
|
2015-06-02 |
2016-12-08 |
E I Du Pont De Nemours And Company |
Substituted cyclic amides and their use as herbicides
|
WO2016198908A1
(en)
|
2015-06-09 |
2016-12-15 |
Abbvie Inc. |
Ror nuclear receptor modulators
|
UY36768A
(es)
|
2015-07-06 |
2017-01-31 |
Bayer Cropscience Ag |
Heterociclos nitrogenados como pesticidas
|
AU2016291578C1
(en)
|
2015-07-10 |
2021-07-15 |
Arvinas Operations, Inc. |
MDM2-based modulators of proteolysis and associated methods of use
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
WO2017051319A1
(en)
|
2015-09-21 |
2017-03-30 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
CN108473503A
(zh)
|
2015-09-30 |
2018-08-31 |
赛特温治疗公司 |
用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物
|
US10874686B2
(en)
|
2015-10-01 |
2020-12-29 |
Memorial Sloan-Kettering Cancer Center |
Anthranilyl-adenosinemonosulfamate analogs and uses thereof
|
US11413278B2
(en)
|
2015-10-08 |
2022-08-16 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
CA3001857A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
DK3362461T3
(da)
|
2015-10-16 |
2022-05-09 |
Modernatx Inc |
Mrna-cap-analoger med modificeret phosphatbinding
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
JP6837004B2
(ja)
|
2015-11-27 |
2021-03-03 |
田辺三菱製薬株式会社 |
新規イミダゾール化合物およびメラノコルチン受容体作動薬としての用途
|
GB201522232D0
(en)
|
2015-12-16 |
2016-01-27 |
Liverpool School Tropical Medicine |
Combination product
|
KR102606339B1
(ko)
|
2016-03-02 |
2023-11-24 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
ES2947636T3
(es)
|
2016-03-16 |
2023-08-14 |
Kura Oncology Inc |
Derivados de tieno[2,3-d]pirimidina sustituida como inhibidores de menina-MLL y métodos de uso
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
WO2017173274A1
(en)
|
2016-03-31 |
2017-10-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
CN105906591A
(zh)
|
2016-04-22 |
2016-08-31 |
中国药科大学 |
2-氨基-γ-丁内酯类盐酸盐的合成
|
TWI763668B
(zh)
*
|
2016-05-05 |
2022-05-11 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
WO2017223260A1
(en)
|
2016-06-23 |
2017-12-28 |
Albert Einstein College Of Medicine, Inc. |
Pu.1 inhibitors
|
CN106220667B
(zh)
|
2016-07-21 |
2018-10-30 |
北京航空航天大学 |
螺环有机硅化合物及其应用
|
WO2018045106A1
(en)
|
2016-08-30 |
2018-03-08 |
Ohio State Innovation Foundation |
Anti-fungal treatment
|
WO2018055235A1
(en)
|
2016-09-21 |
2018-03-29 |
University Of Helsinki |
Isoxazole-amides for treating cardiac diseases
|
WO2018060110A1
(en)
|
2016-09-28 |
2018-04-05 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
WO2018067636A1
(en)
|
2016-10-04 |
2018-04-12 |
Massachusetts Institute Of Technology |
Compositions and methods for selective carbonylation of heterocyclic compounds
|
US11142535B2
(en)
|
2016-12-12 |
2021-10-12 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
|
WO2018138358A1
(en)
|
2017-01-30 |
2018-08-02 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
WO2018163077A1
(en)
*
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
CN108658974A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种内酰胺类化合物及其制备方法和用途
|
CN108658972A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种取代内酰胺类化合物及其制备方法和用途
|
US11279706B2
(en)
|
2017-03-29 |
2022-03-22 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
CA3058214A1
(en)
|
2017-03-29 |
2018-10-04 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
CA3058466A1
(en)
|
2017-03-30 |
2018-10-04 |
Shaw Industries Group, Inc. |
Carpet tiles and systems and methods of making same
|
US20200113901A1
(en)
|
2017-03-31 |
2020-04-16 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
JP2020100564A
(ja)
|
2017-04-03 |
2020-07-02 |
京都薬品工業株式会社 |
リードスルー誘導剤およびその医薬用途
|
WO2018191146A1
(en)
|
2017-04-10 |
2018-10-18 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl rheb inhibitors and uses thereof
|
CN108689942B
(zh)
|
2017-04-11 |
2023-06-09 |
广东东阳光药业有限公司 |
含氮双环化合物及其制备方法和用途
|
JP2020517600A
(ja)
|
2017-04-20 |
2020-06-18 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
K−Rasモジュレーター
|
EP3612181A4
(en)
|
2017-04-21 |
2021-01-06 |
Epizyme, Inc. |
COMBINATION THERAPIES WITH EHMT2 INHIBITORS
|
UA124857C2
(uk)
|
2017-05-16 |
2021-12-01 |
Вертекс Фармасьютикалз Інкорпорейтед |
Дейтеровані піридонаміди і їх проліки як модулятори натрієвих каналів
|
CN107033149B
(zh)
|
2017-06-12 |
2020-01-03 |
上海交通大学 |
一种dpp-4酶抑制剂及其制备和应用
|
CN111051281A
(zh)
|
2017-06-21 |
2020-04-21 |
波涛生命科学有限公司 |
用于合成的化合物、组合物和方法
|
PE20201164A1
(es)
|
2017-07-11 |
2020-10-28 |
Vertex Pharma |
Carboxamidas como moduladores de los canales de sodio
|
CN109320509B
(zh)
|
2017-07-31 |
2022-02-08 |
轩竹生物科技股份有限公司 |
Fxr受体激动剂
|
CN109384712B
(zh)
|
2017-08-14 |
2021-05-07 |
北京宽厚医药科技有限公司 |
靶向nk1受体拮抗剂及其在化疗所致恶心、呕吐治疗中的应用
|
AU2018319016B2
(en)
|
2017-08-17 |
2023-08-31 |
Ikena Oncology, Inc. |
AHR inhibitors and uses thereof
|
WO2019036562A1
(en)
|
2017-08-18 |
2019-02-21 |
Saint Louis University |
ERR INVERSE AGONISTS
|
CN109553608B
(zh)
|
2017-09-26 |
2020-12-08 |
北京大学 |
一类五元六元杂环化合物及其制备方法和治疗肿瘤的用途
|
SG11202003162RA
(en)
|
2017-10-18 |
2020-05-28 |
Epizyme Inc |
Methods of using ehmt2 inhibitors in treating or preventing blood disorders
|
AU2018353139A1
(en)
|
2017-10-18 |
2020-06-04 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors in immunotherapies
|
EP3700527A4
(en)
|
2017-10-25 |
2021-03-10 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND THEIR METHODS OF USE
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
WO2019094732A1
(en)
|
2017-11-10 |
2019-05-16 |
Academia Sinica |
Inhibitors of cyclic-amp response element-binding protein
|
AU2018370096B2
(en)
|
2017-11-15 |
2023-08-31 |
Metabomed Ltd |
ACSS2 inhibitors and methods of use thereof
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
EP3502684A1
(en)
|
2017-12-22 |
2019-06-26 |
Universite De Bordeaux |
Method for metal ion detection in aqueous solutions using nucleolipid compounds
|
CN111315744B
(zh)
|
2018-01-09 |
2023-07-14 |
四川科伦博泰生物医药股份有限公司 |
杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
|
EA202091897A1
(ru)
|
2018-02-08 |
2020-10-27 |
Энио Фарма |
Неконденсированные производные тиофена и их применение
|
CN111918650A
(zh)
|
2018-02-12 |
2020-11-10 |
沃泰克斯药物股份有限公司 |
治疗疼痛的方法
|
JP2021523755A
(ja)
|
2018-04-05 |
2021-09-09 |
セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド |
高密度電極マッピングカテーテル
|
KR20210005159A
(ko)
|
2018-04-27 |
2021-01-13 |
메르크 파텐트 게엠베하 |
중합성 액정 물질 및 중합된 액정 필름
|
WO2019206925A1
(en)
|
2018-04-27 |
2019-10-31 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
US20210221781A1
(en)
|
2018-05-16 |
2021-07-22 |
Lin Bioscience Pty Ltd. |
Fatty acid analogues and methods of use
|
TWI812739B
(zh)
|
2018-06-21 |
2023-08-21 |
景凱生物科技股份有限公司 |
Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用
|
SG11202100137TA
(en)
|
2018-07-09 |
2021-02-25 |
Lieber Institute Inc |
PYRIDAZINE COMPOUNDS FOR INHIBITING Nav1.8
|
CA3105657A1
(en)
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
US20210347785A1
(en)
|
2018-08-01 |
2021-11-11 |
Shanghai Ennovabio Pharmaceuticals Co., Ltd. |
Preparation and application of aromatic compound having immunoregulatory function
|
WO2020033413A2
(en)
|
2018-08-07 |
2020-02-13 |
Tosk, Inc. |
Modulators of ras gtpase
|
WO2020034058A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
PROCESS FOR REDUCTIVE AMINATION OF α,β-UNSATURATED CARBONYL COMPOUND
|
WO2020034062A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
Process for the reductive amination of a carbonyl compound
|
EP3847159A2
(en)
|
2018-09-04 |
2021-07-14 |
Magenta Therapeutics, Inc. |
Aryl hydrocarbon receptor antagonists and methods of use
|
JP2022511374A
(ja)
|
2018-09-28 |
2022-01-31 |
アキュセラ インコーポレイテッド |
Vap-1の阻害剤
|
KR102092838B1
(ko)
|
2018-10-02 |
2020-03-24 |
성균관대학교산학협력단 |
신규 퓨란계 폴리카보네이트 및 이의 제조 방법
|
US20220009938A1
(en)
|
2018-10-03 |
2022-01-13 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
WO2020081572A1
(en)
|
2018-10-15 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereof
|
CA3117927A1
(en)
|
2018-11-02 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors
|
EP3873468A4
(en)
|
2018-11-02 |
2022-10-26 |
Merck Sharp & Dohme LLC |
2-AMINO-N-PHENYL-NICOTINAMIDE USED AS NAV1.8 INHIBITORS
|
KR102151855B1
(ko)
|
2018-11-30 |
2020-09-03 |
롯데케미칼 주식회사 |
공액 디엔계 및 방향족 비닐계 공중합체의 제조 방법 및 이로부터 제조된 공액 디엔계 및 방향족 비닐계의 공중합체를 포함하는 타이어
|
WO2020118036A1
(en)
|
2018-12-06 |
2020-06-11 |
The Children's Medical Center Corporation |
Antibacterial compounds and uses thereof
|
EP3894392A4
(en)
|
2018-12-11 |
2022-08-24 |
Duke University |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
US20230062053A1
(en)
|
2019-01-10 |
2023-03-02 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
KR20210114498A
(ko)
|
2019-01-22 |
2021-09-23 |
메르크 파텐트 게엠베하 |
액정 중합체 필름의 제조 방법
|
AU2019427489A1
(en)
|
2019-01-28 |
2021-07-22 |
Mitochondria Emotion, Inc. |
Mitofusin activators and methods of use thereof
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
WO2020191227A1
(en)
|
2019-03-20 |
2020-09-24 |
Cornell University |
Methods for controlling prostaglandin-mediated biological processes
|
WO2020191501A1
(en)
|
2019-03-27 |
2020-10-01 |
Algernon Pharmaceuticals Inc. |
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
EP3963026A1
(en)
|
2019-04-30 |
2022-03-09 |
Merck Patent GmbH |
Reactive mesogens
|
WO2020228922A1
(de)
|
2019-05-10 |
2020-11-19 |
Wacker Chemie Ag |
Kationische germanium(ii)-verbindungen, verfahren zu deren herstellung und deren verwendung als katalysator in der hydrosilylierung
|
US20230084752A1
(en)
|
2019-05-14 |
2023-03-16 |
Metabomed Ltd. |
Acss2 inhibitors and methods of use thereof
|
US20220324880A1
(en)
|
2019-06-10 |
2022-10-13 |
Kymara Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
BR112021025317A2
(pt)
|
2019-06-21 |
2022-03-15 |
Bayer Ag |
Tienilhidroxiisoxazolinas e derivados das mesmas
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
WO2021074357A1
(en)
|
2019-10-17 |
2021-04-22 |
Enyo Pharma |
Thiophene derivatives for use in treating portal inflammation and fibrosis
|
US11834441B2
(en)
|
2019-12-06 |
2023-12-05 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
EP4079295A4
(en)
|
2019-12-20 |
2023-12-06 |
Samyang Holdings Corporation |
COMPOSITION HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY OF OLAPARIB
|
CN116472292A
(zh)
|
2020-05-28 |
2023-07-21 |
上海睿跃生物科技有限公司 |
经修饰的蛋白质和蛋白质降解剂
|
GB202011996D0
(en)
|
2020-07-31 |
2020-09-16 |
Adorx Therapeutics Ltd |
Antagonist compounds
|
CN116194551A
(zh)
|
2020-09-24 |
2023-05-30 |
默克专利股份有限公司 |
可聚合液晶材料和聚合的液晶膜
|
WO2022070048A1
(en)
|
2020-09-29 |
2022-04-07 |
Cadila Healthcare Limited |
Novel amide derivatives
|
US20230405008A1
(en)
|
2020-10-21 |
2023-12-21 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
EP4347031A1
(en)
|
2021-06-04 |
2024-04-10 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|